| Literature DB >> 33923535 |
Vasileios Tsiouris1, Natalia Mavromati1, Konstantinos Kiskinis1, Tilemachos Mantzios1, Zalan G Homonnay2, Tamas Mato2, Mihaly Albert2, Istvan Kiss2, Ioanna Georgopoulou1.
Abstract
Infectious laryngotracheitis is an economically significant viral disease of chickens, that mainly affects the upper respiratory tract, and is present worldwide. This case reports the first outbreak of infectious laryngotracheitis in a four-week-old organic broiler farm and surrounding flocks in Greece, with typical clinical symptoms and lesions, allegedly provoked by a wild strain of infectious laryngotracheitis virus. Our findings contradict the general perception indicating that the disease appears mainly in older birds and that vaccine strains are the primary cause of infectious laryngotracheitis outbreaks in most continents. A recombinant vectored vaccine was administered, supplementary to biosecurity measures, containing the viral spread. The responsible strain was potentially circulating in the area; therefore, an industry-wide holistic approach was applied, including the vaccination of neighboring broilers and breeders with the same vaccine, the rapid molecular diagnosis of the disease, and strict biosecurity protocols. The results of this holistic effort were effective because, following the application of vaccine and management protocols, manifestations of the disease in regional flocks dropped significantly, and there was no recurrence to date. These findings suggest that vaccination protocols should be modified, especially for organic broilers, to include vaccination against infectious laryngotracheitis.Entities:
Keywords: broiler chicken; infectious laryngotracheitis; organic farm; vaccinal strain; wild strain
Year: 2021 PMID: 33923535 PMCID: PMC8073223 DOI: 10.3390/vetsci8040064
Source DB: PubMed Journal: Vet Sci ISSN: 2306-7381
Figure 1A 33-day-old broiler chicken with typical symptoms of ILT. In particular, bloody mucoid ocular exudate which soiled both the plumage (right) and the walls of the poultry house (left).
Figure 2The trachea of a 33-day-old broiler chicken with typical symptoms of ILT, where hemorrhage and congestion of the trachea are visible, accompanied by bloody mucoid exudate in the lumen.
Figure 3Histology of the trachea from a broiler chicken. Mucosa is thickened, epithelium is edematous, congested (arrow). Mucosa and submucosa are heavily infiltrated by lymphocytes and plasma cells (arrowhead). H.E. stain; M: 250×.
Figure 4ILT, trachea from a broiler. Intranuclear viral inclusion body in an epithelial cell (arrow). H.E. stain; M: 400×.
The list of sequences from GenBank which are identical with the Greek strain based on the TK gene sequence.
| Acc. No. | Strain ID | Country | Year | Reference |
|---|---|---|---|---|
| MF405080 | Rus/Ck/Penza/2013/2701 | Russia | 2013 | - |
| MG775240 | TN 41/17 | Tunisia | 2017 | - |
| EU360946 | CH04 | Switzerland | Unknown | [ |
| HM230794 | 288269/2007 | Italy | 2007 | [ |
| KP677883 | 193435/07 | Italy | 2007 | [ |
| KP677884 | 757/11 | Italy | 2007 | [ |
| KP677885 | 4787/80 | Italy | 2007 | [ |
Summarized results of the positions of nucleotide changes according to Neff et al., 2008 [16]. Dots represent positions identical to the D5203/3/4 sequence, nucleotide bases of the DNA are represented by A (adenine), C (cytosine), G (guanine) and T (thymine).
| GenBank Acc. No. | Strain ID | 29 | 428 | 513 | 540 | 643 | 650 | 965 | 1014 | 1025 |
|---|---|---|---|---|---|---|---|---|---|---|
| D5203/3/4 | C | T | A | T | T | G | C | T | C | |
| D5203/3/5 | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | |
| MF405080 | Rus/Ck/Penza/2013/2701 | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ |
| MG775240 | TN 41/17 | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ |
| EU360946 | CH04 | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ |
| HM230794 | 288269/2007 | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ |
| KP677883 | 193435/07 | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ |
| KP677884 | 757/11 | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ |
| KP677885 | 4787/80 | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ | ∙ |
| EU360950 | TCO | ∙ | ∙ | ∙ | C | ∙ | ∙ | ∙ | ∙ | ∙ |
| EU360949 | CEO | ∙ | ∙ | ∙ | C | ∙ | ∙ | ∙ | ∙ | ∙ |
| JN580317 | CEO_low_passage | ∙ | ∙ | ∙ | C | ∙ | ∙ | ∙ | ∙ | ∙ |
| JN580316 | CEO_high_passage | ∙ | ∙ | ∙ | C | ∙ | ∙ | ∙ | ∙ | ∙ |
| JQ083494 | vaccine_Laryngo_Vac | ∙ | ∙ | ∙ | C | ∙ | ∙ | ∙ | ∙ | ∙ |
| EU423895 | SL-Laryngo-vac | ∙ | ∙ | ∙ | C | ∙ | ∙ | ∙ | C | ∙ |
| EU423888 | FDL-Laryngo-vac | ∙ | C | T | C | ∙ | ∙ | ∙ | ∙ | ∙ |
| EU423897 | SP-Trachivax | ∙ | ∙ | ∙ | C | ∙ | A | ∙ | ∙ | ∙ |
| EU423891 | Isbi-Bio-Laryngo | A | ∙ | ∙ | C | ∙ | ∙ | T | ∙ | ∙ |
| EU423890 | II-Nobilis-ILT | ∙ | ∙ | ∙ | C | C | ∙ | ∙ | ∙ | T |
| KP677881 | Nobilis_Laringovac | ∙ | ∙ | ∙ | C | ∙ | ∙ | ∙ | ∙ | ∙ |
| KP677882 | Poulvac_ILT | ∙ | ∙ | ∙ | C | ∙ | ∙ | ∙ | ∙ | ∙ |
| HQ630064 | Serva | ∙ | ∙ | ∙ | C | ∙ | ∙ | ∙ | ∙ | ∙ |